97
Views
59
CrossRef citations to date
0
Altmetric
Original Article

Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet

, &
Pages 115-127 | Received 26 Aug 1999, Published online: 07 Jul 2009

References

  • Morrow J.D., Hill K.E., Burk R.E., Nammour T.M., Badr K.F., Roberts L.J., II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proceedings of the National Academy of Sciences of the USA 1990; 87: 9383–9387
  • Morrow J.D., Awad J.A., Kato T., Takahashi K., Badr K.F., Roberts L.J., II, Burk R.F. Formation of novel noncyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. Journal of Clinical Investigation 1992; 90: 2502–2507
  • Gopaul N.K., Änggård E.E., Mallet A.I., Betteridge D.J., Wolff S.P., Nourooz-Zadeh J. Plasma levels of 8-epi-PGF2α are elevated in individuals with non-insulin-dependent diabetes mellitus. FEBS Letters 1995; 368: 225–229
  • Davi G., Alessandrini P., Mezzetti A., Minotti G., Bucciarelli T., Costantini F., Cipollone F., Bittolo-Bon G.G., Ciabattoni G., Patrono C. In vivo formation of 8-epi-prostaglandin F2α is increased in hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology 1997; 17: 3230–3235
  • Davi G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., Pennese E., Vitacolonna E., Bucciarelli T., Costantini F., Capani F., Patrono C. In vivo formation of 8-epi-prostaglandin F2α and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224–229
  • Pratico D., Iuliano L., Basili S., Ferro D., Camastra C., Cordova C., Riggio O., FitzGerald G.A., Violi F. Enhanced lipid peroxidation in hepatic cirrhosis. Journal of Investigative Medicine 1998; 46: 51–57
  • Pratico D., Lee V.M.-Y., Trojanowski J.Q., Rokach J., FitzGerald G.A. Increased F2-isoprostanes in Alzheimer's disease: Evidence of enhanced lipid peroxidation in vivo. FASEB Journal 1998; 12: 1777–1783
  • Delanty N., Reilly M., Pratico D., Lawson J.A., McCarthy J.F., Wood A.E., Ohnishi S.T., FitzGerald D.J., FitzGerald G.A. 8-epi-PGF2α generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo. Circulation 1997; 95: 2492–2499
  • Reilly M., Pratico D., Lanken P., Delanty N., Rokach J., Lawson J.A., FitzGerald G.A. Isoprostanes in the assessment of oxidant stress in vivo. Molecular and Cellular Basis of Inflammation, C.N. Serhan, P.A. Ward. Humana Press Inc., New York 1998; 127–139, In
  • Palmer A.M., Thomas C.R., Gopaul N., Dhir S., Änggård E.E., Poston L., Tribe R.M. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 1998; 41: 148–156
  • Laight D.W., Desai K.M., Gopaul N.K., Änggård E.E., Carrier M.J. Dietary vitamin E reduces oxidant stress and improves insulin action in the obese Zucker rat in vivo. British Journal of Pharmacology 1998; 125(SS)114–114
  • Chowienczyk P.J., Brett S.E., Gopaul N.K., Dhir S., Meeking D., Marchetti M., Russell-Jones D.L., Änggård E.E., Ritter J.M. Oral administration of a novel water-soluble antioxidant reduces oxidative stress and improves endothelial function in non-insulindependent diabetes. Circulation 1998; 98(SS)901–901
  • Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radical Research 1996; 25: 57–74
  • Bell A.C., Parnell W.R. Nutrient intakes of Tongan and Tokelauan children living in New Zealand. New Zealand Medical Journal 1996; 109: 435–438
  • Watt R.G., Sheiham A. Dietary patterns and changes in inner city adolescents. Journal of Human Nutrition and Dietetics 1996; 9: 451–461
  • Diehl J.M. Food preferences of 10- to 14-year-old boys and girls. Schweizerische Medizinische Wochenschrift 1999; 129: 151–161
  • Staprans I., Rapp J.H., Pan X.M., Feingold K.R. Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. Journal of Lipid Research 1996; 37: 420–430
  • Staprans I., Hardman D.A., Pan X.M., Feingold K.R. Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients. Diabetes Care 1999; 22: 300–306
  • Morrow J.D., Awad J.A., Boss H.J., Blair I.A., Roberts L.J., II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proceedings of the National Academy of Sciences of the USA 1992; 89: 10721–10725
  • Banerjee M., Kang K.H., Morrow J.D., Roberts L.J., II, Newman J.H. Effects of a novel prostaglandin, 8-epi-PGF2α, in rabbit lung in situ. American Journal of Physiology 1992; 263: H660–H663, (Heart and Circulation Physiology, 32)
  • Pratico D., Smyth E.M., Violi F., FitzGerald G.A. Local amplification of platelet function by 8-epi-PGF2α is not mediated by thromboxane receptor isoforms. Journal of Biological Chemistry 1996; 271: 14916–14924
  • Kunapuli P., Lawson J.A., Rokach J.A., Meinkoth J.L., FitzGerald G.A. Prostaglandin F2α and the isoprostane 8,12-iso-isoprostane F2α-III, induce cardiomyocyte hypertrophy — Differential activation of downstream signaling pathways. Journal of Biological Chemistry 1998; 273: 22442–22452
  • Nourooz-Zadeh J., Gopaul N.K., Barrow S., Mallet A.I., Änggård E.E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: Development of a solid-phase extraction procedure. Journal of Chromatography, series B 1995; 667: 199–208
  • Jiang Z.Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low density lipoprotein. Analytical Biochemistry 1992; 202: 384–389
  • Ohta A., Mayo M.C., Kramer N., Lands W.E.M. Rapid analysis of fatty acids in plasma lipids. Lipids 1990; 25: 742–747
  • Aw T.Y. Determinants of intestinal detoxication of lipid hydroperoxides. Free Radical Research 1998; 28: 637–646
  • Kanner J., German J.B., Kinsella J.E. Initiation of lipid peroxidation in biological systems. CRC Critical Reviews in Food Science and Nutrition 1987; 25: 317–364
  • Mori T.A., Croft K.D., Puddey I.B., Beilin L.J. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography mass spectrometry. Analytical Biochemistry 1999; 268: 117–125
  • Guyton A.C. Digestion and absorption in the gastrointestinal tract. Textbook of Medical Physiology. W.B. Saunders Company, Philadelphia 1986, In 789 pp
  • Basu S. Metabolism of 8-iso-prostaglandin-F2α. FEBS Letters 1998; 428: 32–36
  • Keller C., Escher F., Solms J. Nutrient retention in deep-fat frying — case study on French fried potatoes. Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene 1989; 81: 68–81
  • Fillion L., Henry C.J.K. Nutrient losses and gains during frying: A review. International Journal of Food Science and Nutrition 1998; 49: 157–168
  • Holland B., Welch A.A., Unwin I.D., Buss D.H., Paul A.A., Southgate D.A.T. The Composition of Foods. Royal Society of Chemistry, Cambridge 1991
  • Hubbard W.D., Prosser A.R., Sheppard A.J., Newkirk D.R., Osgood T., Tombropoulos E., Jones S.T. Individual lipids and proximate analysis of various foods — 1. French fried potatoes from ten chain restaurants. Journal of Agricultural and Food Chemistry 1977; 25: 1280–1281
  • Wills R.B.H., Greenfield H. Composition of Australian foods. 3. Foods from a major fast-food chain. Food Technology 1980; 32: 363–366
  • Nourooz-Zadeh J., Liu E.H.C., Yhlen B., Änggård E.E., Halliwell B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. Journal of Neurochemistry 1999; 72: 734–740
  • Roberts L.J., II, Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. Journal of Biological Chemistry 1998; 273: 13605–13612

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.